GlassScriptPhysician profile
Henry A Hull
NPI 1770565772
$3,099.51
in general payments reported to CMS, 2019-2025
20 companies · $735 in 2025
The $735 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2020: $488 · 2021: $272 · 2022: $229 · 2023: $496 · 2024: $273 · 2025: $735.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $610.22 | 2019-2025 | |
| Coopervision INC. | $380.57 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Biofinity Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $291.27 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $262.98 | 2019-2023 | Cequa |
| Abbvie INC. | $200.16 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $156.27 | 2023-2024 | Infuse, Biotrue One Day, Xiidra |
| Novartis Pharmaceuticals Corporation | $153.41 | 2020-2023 | |
| Eyevance Pharmaceuticals LLC | $140.64 | 2021 | |
| Lkc Technologies, INC. | $132.24 | 2025 | |
| Regeneron Pharmaceuticals, INC. | $130.02 | 2023 | Eylea |
| Astellas Pharma US INC | $115.06 | 2024 | Izervay |
| Glaukos Corporation | $107.27 | 2019-2025 | Idosetr |
| Tarsus Pharmaceuticals, INC. | $96.36 | 2025 | Xdemvy |
| Allergan, INC. | $69.30 | 2020-2021 | |
| Ivantis, INC | $68.00 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $62.33 | 2023-2025 | Precision7, Total30 |
| Sight Sciences, INC. | $61.96 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $26.42 | 2024 | |
| Abb Con-Cise Optical Group LLC | $20.47 | 2019 | |
| Oyster Point Pharma, INC. | $14.56 | 2025 | Ryzumvi, Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Hull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.